Skip to main content
NCBI home page
Thorax logoLink to Thorax
editorial
. 1993 Oct;48(10):957–958. doi: 10.1136/thx.48.10.957

Drug resistant tuberculosis: problems on the horizon.

L P Ormerod
PMCID: PMC464796  PMID: 8256241

Full text

PDF
957

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aziz A., Siddiqi S. H., Aziz K., Ishaq M. Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan. Tubercle. 1989 Mar;70(1):45–51. doi: 10.1016/0041-3879(89)90064-0. [DOI] [PubMed] [Google Scholar]
  2. Brisson-Noël A., Gicquel B., Lecossier D., Lévy-Frébault V., Nassif X., Hance A. J. Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet. 1989 Nov 4;2(8671):1069–1071. doi: 10.1016/s0140-6736(89)91082-9. [DOI] [PubMed] [Google Scholar]
  3. Das S., Chan S. L., Allen B. W., Mitchison D. A., Lowrie D. B. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuber Lung Dis. 1993 Feb;74(1):47–51. doi: 10.1016/0962-8479(93)90068-9. [DOI] [PubMed] [Google Scholar]
  4. De Wit D., Steyn L., Shoemaker S., Sogin M. Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification. J Clin Microbiol. 1990 Nov;28(11):2437–2441. doi: 10.1128/jcm.28.11.2437-2441.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Di Perri G., Cruciani M., Danzi M. C., Luzzati R., De Checchi G., Malena M., Pizzighella S., Mazzi R., Solbiati M., Concia E. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989 Dec 23;2(8678-8679):1502–1504. [PubMed] [Google Scholar]
  6. Dooley S. W., Jr, Castro K. G., Hutton M. D., Mullan R. J., Polder J. A., Snider D. E., Jr Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Recomm Rep. 1990 Dec 7;39(RR-17):1–29. [PubMed] [Google Scholar]
  7. Etemadi A., Farid R., Stanford J. L. Immunotherapy for drug-resistant tuberculosis. Lancet. 1992 Nov 28;340(8831):1360–1361. doi: 10.1016/0140-6736(92)92551-p. [DOI] [PubMed] [Google Scholar]
  8. FOX W., WIENER A., MITCHISON D. A., SELKON J. B., SUTHERLAND I. The prevalence of drug-resistant tubercle bacilli in untreated patients with pulmonary tuberculosis; a national survey, 1955-56. Tubercle. 1957 Apr;38(2):71–84. doi: 10.1016/s0041-3879(57)80001-4. [DOI] [PubMed] [Google Scholar]
  9. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
  10. Goble M., Iseman M. D., Madsen L. A., Waite D., Ackerson L., Horsburgh C. R., Jr Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993 Feb 25;328(8):527–532. doi: 10.1056/NEJM199302253280802. [DOI] [PubMed] [Google Scholar]
  11. Hermans P. W., van Soolingen D., Dale J. W., Schuitema A. R., McAdam R. A., Catty D., van Embden J. D. Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis. J Clin Microbiol. 1990 Sep;28(9):2051–2058. doi: 10.1128/jcm.28.9.2051-2058.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kennedy N., Billington O., Mackay A., Gillespie S. H., Bannister B. Re-emergence of tuberculosis. BMJ. 1993 Feb 20;306(6876):514–514. doi: 10.1136/bmj.306.6876.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McCarthy O. R. Asian immigrant tuberculosis--the effect of visiting Asia. Br J Dis Chest. 1984 Jul;78(3):248–253. [PubMed] [Google Scholar]
  14. Miller A. B., Tall R., Fox W., Lefford M. J., Mitchison D. A. Primary drug resistance in pulmonary tuberculosis in Great Britain: second national survey, 1963. Tubercle. 1966 Mar;47(1):92–108. doi: 10.1016/s0041-3879(66)80053-3. [DOI] [PubMed] [Google Scholar]
  15. Ormerod L. P., Harrison J. M., Wright P. A. Drug resistance in Mycobacterium tuberculosis: a survey over 25 years in Blackburn. Thorax. 1986 Dec;41(12):946–950. doi: 10.1136/thx.41.12.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ormerod L. P., Harrison J. M., Wright P. A. Drug resistance trends in Mycobacterium tuberculosis: Blackburn 1985-89. Tubercle. 1990 Dec;71(4):283–285. doi: 10.1016/0041-3879(90)90042-7. [DOI] [PubMed] [Google Scholar]
  17. Otal I., Martín C., Vincent-Lévy-Frebault V., Thierry D., Gicquel B. Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis. J Clin Microbiol. 1991 Jun;29(6):1252–1254. doi: 10.1128/jcm.29.6.1252-1254.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pablos-Mendez A., Raviglione M. C., Battan R. Drug-resistant tuberculosis in AIDS. Chest. 1990 Feb;97(2):511–512. doi: 10.1378/chest.97.2.511a. [DOI] [PubMed] [Google Scholar]
  19. Pitchenik A. E., Burr J., Laufer M., Miller G., Cacciatore R., Bigler W. J., Witte J. J., Cleary T. Outbreaks of drug-resistant tuberculosis at AIDS centre. Lancet. 1990 Aug 18;336(8712):440–441. doi: 10.1016/0140-6736(90)91987-l. [DOI] [PubMed] [Google Scholar]
  20. Pretet S., Lebeaut A., Parrot R., Truffot C., Grosset J., Dinh-Xuan A. T. Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection). Eur Respir J. 1992 Jun;5(6):680–684. [PubMed] [Google Scholar]
  21. Scalcini M., Carré G., Jean-Baptiste M., Hershfield E., Parker S., Wolfe J., Nelz K., Long R. Antituberculous drug resistance in central Haiti. Am Rev Respir Dis. 1990 Sep;142(3):508–511. doi: 10.1164/ajrccm/142.3.508. [DOI] [PubMed] [Google Scholar]
  22. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
  23. Shafer R. W., Chirgwin K. D., Glatt A. E., Dahdouh M. A., Landesman S. H., Suster B. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS. 1991 Apr;5(4):399–405. doi: 10.1097/00002030-199104000-00007. [DOI] [PubMed] [Google Scholar]
  24. Trivedi S. S., Desai S. G. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle. 1988 Mar;69(1):37–42. doi: 10.1016/0041-3879(88)90038-4. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES